141853-26-1Relevant articles and documents
3,4-dihydropyrido[4,3-d]pyrimidine derivative, and preparation method and use thereof
-
Paragraph 0069; 0072; 0077; 0078, (2019/10/07)
The invention relates to a 3,4-dihydropyrido[4,3-d]pyrimidine derivative, and a preparation method and a use thereof. The compound is a compound represented by formula I, or a pharmaceutically acceptable salt or stereoisomer or tautomer thereof, and R to R are as defined in the description.
COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
-
Paragraph 0350, (2017/02/24)
Compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein A, J, R1, R2, R3, R4, R5, R6, R7, R9, X, m and n are as described herein, compositions thereof, and methods and uses thereof.
Inotropic polyazapentalene sulmazole analogues
Barraclough,Black,Cambridge,Firmin,Gerskowitch,Glen,Giles,Gillam,Hull,Iyer,Randall,Shah,Smith,Whiting
, p. 225 - 234 (2007/10/02)
Aryl substituted 1H-imidazo[1,2-a]imidazole 8, imidazo[2,1-b]thiazole 9,1,4-dihydroimidazo[4,5-d]imidazole 11, and 1(2),4-dihydroimidazo[4,5-c]pyrazoles 12-17 have been prepared. An X-ray crystallographic study confirmed the structure of 8 and showed this
